Concepedia

Bernadette Pascual

BP

Statistics

Publications

10

Citations

404

H-Index

10

Active since

2002

Affiliations

Pfizer (United States)(Current)

Ligand Pharmaceuticals (United States)

Bernadette Pascual is an author at Pfizer (United States) specializing in medicine, pharmacology, and cancer pharmacology.

Publications per year

2002–2025

10

Publications

10

Mechanism of Selective Retinoid X Receptor Agonist-Induced Hypothyroidism in the Rat

Sha Liu, Kathleen M. Ogilvie, Kay Klausing et al. · Endocrinology · 2002 · 72 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes

Mark D. Leibowitz, Robert Ardecky, Marcus F. Boehm et al. · Endocrinology · 2005 · 70 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood–Brain Barrier

Allison Rohner, Mary E. Spilker, Justine L. Lam et al. · Molecular Cancer Therapeutics · 2011 · 51 citations

Medicine, Oncology, Pharmacology +17

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies

Shu‐Hui Liu, Yin Gu, Bernadette Pascual et al. · Blood Advances · 2017 · 51 citations · Full text

Medicine, Hematology, Pharmacology +11

CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety

Cynthia L. Palmer, Britton Boras, Bernadette Pascual et al. · Cancer Cell · 2025 · 51 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 10